Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0UU0V
|
|||
| Drug Name |
1,5-di-substituted pyridine derivative 1
|
|||
| Synonyms |
PMID26161698-Compound-26
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
LEAD DISCOVERY CENTER GMBH [DEBAYER IP GMBH [DE];
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C19H19N3O3S
|
|||
| Canonical SMILES |
COC1=CC=CC=C1C2=CC(=NC=C2)NC3=CC=CC(=C3)CS(=O)(=O)N
|
|||
| InChI |
1S/C19H19N3O3S/c1-25-18-8-3-2-7-17(18)15-9-10-21-19(12-15)22-16-6-4-5-14(11-16)13-26(20,23)24/h2-12H,13H2,1H3,(H,21,22)(H2,20,23,24)
|
|||
| InChIKey |
WIMRMIUJTYQVQS-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Cyclin-dependent kinase inhibitors for cancer therapy: a patent review (2009 - 2014).Expert Opin Ther Pat. 2015;25(9):953-70. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.